Intravascular guidance of medical devices such as guidewires and catheters typically requires fluoroscopic methods for tracking tips of the medical devices and determining whether the tips are appropriately localized in their target anatomical structures. Such fluoroscopic methods expose clinicians and patients alike to harmful X-ray radiation. In some cases, the patients are exposed to potentially harmful contrast media needed for the fluoroscopic methods. Magnetic and electromagnetic means for tracking the tips of the medical devices obviate some of the foregoing issues with respect to exposure to radiation and potentially harmful contrast media, but the magnetic and electromagnetic means for tracking the tips of the medical devices are prone to interference.
Disclosed herein are optical tip-tracking systems and methods thereof that address the foregoing.
Disclosed herein is an optical tip-tracking system including, in some embodiments, a light-emitting stylet, a light detector, and a console configured to operably connect to the light-emitting stylet and the light detector. The light-emitting stylet is configured to be disposed in a lumen of a catheter. The light-emitting stylet includes a light source in a distal-end portion of the light-emitting stylet configured to emit light. The light detector is configured to be placed over a patient. The light detector includes a plurality of photodetectors configured to detect the light emitted from the light source. The console includes memory and a processor configured to instantiate an optical tip-tracking process for optically tracking the distal-end portion of the light-emitting stylet while the light-emitting stylet is disposed in a vasculature of the patient, the light source is emitting light, the light detector is disposed over the light-emitting stylet, and the photodetectors are detecting the light emitted from the light source.
In some embodiments, the light source is a light-emitting diode (“LED”).
In some embodiments, the light emitted from the light source has a center wavelength between about 650 nm to 1350 nm.
In some embodiments, the light emitted from the light source has a center wavelength between about 650 nm to 950 nm.
In some embodiments, the distal-end portion of the light-emitting stylet is configured to directionally emit light in one or more chosen directions.
In some embodiments, the light detector includes a housing having a patient-facing portion of the housing configured to transmit at least a portion of the light emitted from the light source to the photodetectors.
In some embodiments, the housing has a light-blocking portion of the housing opposite the patient-facing portion configured to block ambient light from the photodetectors.
In some embodiments, the photodetectors are arranged in an array such that the light emitted from the light source remains detectable by at least one photodetector of the photodetectors even when the light emitted from the light source is anatomically blocked from another one or more photodetectors of the photodetectors.
In some embodiments, the optical tip-tracking process is configured to provide tracking information as input to a display server of the console for optically tracking the distal-end portion of the light-emitting stylet in a graphical user interface on a display.
In some embodiments, the light-emitting stylet is configured to directly connect to the console.
In some embodiments, the light-emitting stylet is configured to indirectly connect to the console through an intervening multi-use cable.
In some embodiments, the light-emitting stylet is configured to indirectly connect to the console through the light detector.
In some embodiments, the light detector is configured to be placed over the patient and under a sterile drape. The light-emitting stylet includes a drape-piercing connector having a piercing element configured to pierce the sterile drape and insert into a receptacle of a light-detector connector extending from the light detector under the drape.
Also disclosed herein is an optical tip-tracking system including, in some embodiments, a catheter, a light-emitting stylet for the catheter, a light detector, and a console configured to operably connect to the light-emitting stylet and the light detector. The catheter includes a lumen extending through the catheter. The light-emitting stylet is configured to be disposed in a lumen of a catheter. The light-emitting stylet includes a light-emitting diode (“LED”) in a distal-end portion of the light-emitting stylet configured to emit light having a center wavelength between about 650 nm to 1350 nm. The light detector is configured to be placed over a patient. The light detector includes a plurality of photodetectors configured to detect the light emitted from the LED. The console includes memory and a processor configured to instantiate an optical tip-tracking process for optically tracking the distal-end portion of the light-emitting stylet in a graphical user interface on a display while the light-emitting stylet is disposed in a vasculature of the patient, the LED is emitting light, the light detector is disposed over the light-emitting stylet, and the photodetectors are detecting the light emitted from the LED.
In some embodiments, the light detector is configured to be placed over the patient and under a sterile drape. The light-emitting stylet includes a drape-piercing connector configured to pierce the sterile drape and connect with a light-detector connector extending from the light detector under the drape.
Also disclosed herein is an optical tip-tracking system including, in some embodiments, a light-emitting stylet, a light detector, and a console configured to operably connect to the light-emitting stylet and the light detector. The light-emitting stylet is configured to be disposed in a lumen of a catheter. The light-emitting stylet includes an optical fiber configured to convey light to a distal-end portion of the light-emitting stylet for emitting light therefrom. The light detector is configured to be placed over a patient. The light detector includes a plurality of photodetectors configured to detect the light emitted from the light source. The console includes a light source for the light emitting stylet and memory and a processor. The memory and the processor are configured to instantiate an optical tip-tracking process for optically tracking the distal-end portion of the light-emitting stylet while the light-emitting stylet is disposed in a vasculature of the patient, the light source is emitting light, the light detector is disposed over the light-emitting stylet, and the photodetectors are detecting the light emitted from the light source.
Also disclosed herein is a method of an optical tip-tracking system including, in some embodiments, a disposing step of disposing a light-emitting stylet of the optical tip-tracking system in a lumen of a catheter. The light-emitting stylet includes a light source in a distal-end portion of the light-emitting stylet. The method also includes a placing step of placing a light detector of the optical tip-tracking system over a patient. The light detector includes a plurality of photodetectors. The method also includes an advancing step of advancing the catheter from an insertion site to a destination within a vasculature of the patient while emitting light from the light source and detecting the light with the photodetectors. The method also includes a viewing step of viewing a display screen of the optical tip-tracking system while the display screen graphically tracks the distal-end portion of the light-emitting stylet through the vasculature of the patient.
In some embodiments, the light source of the light-emitting stylet distally extends beyond a distal end of the catheter while advancing the catheter, thereby enabling the photodetectors of the light detector to detect the light emitted from the light source.
In some embodiments, the method also includes a placing step of placing a sterile drape over both the patient and the light detector. The method also includes a connecting step of connecting a drape-piercing connector of the light-emitting stylet with a light-detector connector extending from the light detector. The connecting step includes piercing the sterile drape with a piercing element of the drape-piercing connector before inserting the piercing element into a receptacle of the light-detector connector.
In some embodiments, the catheter is a central venous catheter (“CVC”). The advancing step includes advancing the CVC with the light-emitting stylet disposed therein through a right internal jugular vein, a right brachiocephalic vein, and into a superior vena cava (“SVC”).
In some embodiments, the catheter is a peripherally inserted central catheter (“PICC”). The advancing step includes advancing the PICC with the light-emitting stylet disposed therein through a right basilic vein, a right axillary vein, a right subclavian vein, a right brachiocephalic vein, and into an SVC.
In some embodiments, the method also includes a ceasing step of ceasing to advance the catheter through the vasculature of the patient after determining the distal-end portion of light-emitting stylet is located at the destination by way of the display screen.
These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal-end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal-end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal-end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal-end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
Again, fluoroscopic methods typically used for tracking tips of medical devices such as guidewires and catheters expose clinicians and patients alike to harmful X-ray radiation. Magnetic and electromagnetic means for tracking the tips of the medical devices obviate some of the foregoing issues with respect to exposure to radiation, but the magnetic and electromagnetic means for tracking the tips of the medical devices are prone to interference.
Disclosed herein are optical tip-tracking systems and methods thereof that address the foregoing.
Optical Tip-Tracking Systems
As shown, the optical tip-tracking system 100 or 200 includes a light-emitting stylet 110, a light detector 120, and a console 130 or 230 configured to operably connect to the light-emitting stylet 110 and the light detector 120. Each optical tip-tracking system of the optical tip-tracking systems 100 and 200 also includes a display screen; however, the optical tip-tracking system 100 includes a standalone display screen 140, whereas the optical tip-tracking system 200 includes an integrated display screen 240. Each optical tip-tracking system of the optical tip-tracking systems 100 and 200 can also include a medical device 150 such as the catheter 450 of
Beginning with the consoles 130 and 230, the console 130 or 230 includes memory 134 such as primary memory 136 and secondary memory 138. The primary memory 136 includes random-access memory (“RAM”). The secondary memory 138 includes non-volatile memory such as read-only memory (“ROM”) including a set of instructions 139 or 239 for loading into the primary memory 136 at runtime of the console 130 or 230.
One or more processors 132 are configured to instantiate an optical tip-tracking process in accordance with the instructions 139 or 239 for optically tracking a distal-end portion of the light-emitting stylet 110 while the light-emitting stylet 110 is disposed in a vasculature of a patient, a light source such as one or more LEDs 112 is emitting light, the light detector 120 is disposed over the light-emitting stylet 110, and a plurality of photodetectors of the light detector 120 such as photodetectors 122 are detecting the light emitted from the light source of the light-emitting stylet 110. The optical tip-tracking process is configured to provide tracking information as input to a display server of the console 130 or 230 for optically tracking the distal-end portion of the light-emitting stylet 110 in a graphical user interface on the display screen 140 or 240. Optically tracking the distal-end portion of the light-emitting stylet 110 can be animated on the display screen 140 or 240 as shown on the display screen 240 of the console 230 in
The left-hand side of each figure or
The right-hand side of each figure of
Both connection options of
In addition to
As set forth above, the light detector 120 is configured to be placed over a patient and under a sterile drape such as the sterile drape 801 of
The light detector 120 includes the photodetectors 122 disposed within the light detector 120 configured to detect the light emitted from the light source of the light-emitting stylet 110. The photodetectors 122 are arranged in an array such that the light emitted from the light source of the light-emitting stylet 110 remains detectable by at least one photodetector of the photodetectors 122 even when the light emitted from the light source of the light-emitting stylet 110 is anatomically blocked (e.g. by a rib) from another one or more photodetectors of the photodetectors 122.
The light detector 120 includes a housing having a patient-facing portion 722 of the housing configured to transmit at least a portion of the light emitted from the light source of the light-emitting stylet 110 to the photodetectors 122 disposed within the light detector 120. The housing also has a light-blocking portion 724 of the housing opposite the patient-facing portion 722 of the housing configured to block ambient light from the photodetectors 122 disposed within the light detector 120. In addition to the light-blocking portion 724 of the housing of the light detector 120, the sterile drape 801 also protects the photodetectors 122 from the ambient light while in use.
In addition to
As set forth in more detail below, the light-emitting stylet 110 is configured to be disposed in a lumen of a catheter.
With respect to the light-emitting stylet 110 having the one-or-more LEDs 112 as the light source, the light-emitting stylet 110 includes the one-or-more LEDs 112 in a distal-end portion (e.g., a tip) of the light-emitting stylet 110 configured to emit light. The light-emitting stylet 110 also includes at least a pair of electrical leads 114 configured to convey electrical power from the console 130 or 230 to power the one-or-more LEDs 112. The distal-end portion of the light-emitting stylet 110 can be configured to directionally emit light from the one-or-more LEDs 112 in one or more chosen directions such as straight ahead in line with the light-emitting stylet 110, radially outward such as toward an extracorporeal surface of a patient, or a combination thereof.
With respect to the light-emitting stylet 110 having the external light source, the light-emitting stylet 110 includes an optical fiber 615 configured to convey light from the external source, for example, a light within the console 130 or 230, to the distal-end portion (e.g., the tip) of the light-emitting stylet 110 to emit light. A ferrule 613 disposed over a distal-end portion of the optical fiber 615 can be configured to directionally emit light from the optical fiber 615 in one or more chosen directions such as straight ahead in line with the light-emitting stylet 110, radially outward such as toward an extracorporeal surface of a patient, or a combination thereof.
The light emitted from the light source can have a center wavelength between about 650 nm to 1350 nm including a center wavelength between about 650 nm to 950 nm or a center wavelength between about 1100 nm to 1350 nm. The light in the foregoing ranges of wavelengths is within an optical window for biological tissue in that such light penetrates biological tissue more deeply than light outside the foregoing ranges of wavelengths. (See
Adverting to
Continuing with the example of the diluminal catheter, the catheter 450 includes two lumens extending therethrough formed of adjoining lumen portions. Indeed, the catheter tube 452 includes two catheter-tube lumens 553. (See
Methods
A method of the optical tip-tracking system 100 or 200 includes a disposing step of disposing the light-emitting stylet 110 of the optical tip-tracking system 100 or 200 in a lumen of the catheter 450.
The method also includes a placing step of placing the light detector 120 of the optical tip-tracking system 100 or 200 over the patient P as shown in
The method also includes a placing step of placing the sterile drape 801 over both the patient P and the light detector 120.
As shown in
The method also includes an advancing step of advancing the catheter 450 from an insertion site to a destination within a vasculature of the patient P while emitting light from the light source (e.g., the one-or-more LEDs 112) and detecting the light with the photodetectors 122. The light source of the light-emitting stylet 110 should distally extends beyond a distal end of the catheter 450 while advancing the catheter 450, thereby enabling the photodetectors 122 of the light detector 120 to detect the light emitted from the light source of the light-emitting stylet 110.
When the catheter 450 is a CVC, the advancing step includes advancing the CVC with the light-emitting stylet 110 disposed therein through a right internal jugular vein, a right brachiocephalic vein, and into an SVC.
When the catheter 450 is a PICC, the advancing step includes advancing the PICC with the light-emitting stylet 110 disposed therein through a right basilic vein, a right axillary vein, a right subclavian vein, a right brachiocephalic vein, and into an SVC.
The method also includes a viewing step of viewing the display screen 140 or 240 of the optical tip-tracking system 100 or 200 while the display screen 140 or 240 graphically tracks the distal-end portion of the light-emitting stylet 110 through the vasculature of the patient P.
The method also includes a ceasing step of ceasing to advance the catheter 450 through the vasculature of the patient P after determining the distal-end portion of the light-emitting stylet 110 is located at the destination by way of the display screen 140 or 240.
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application claims the benefit of priority to U.S. Patent Application No. 62/940,107 filed Nov. 25, 2019, which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
4813429 | Eshel et al. | Mar 1989 | A |
5099845 | Besz et al. | Mar 1992 | A |
5163935 | Black et al. | Nov 1992 | A |
5207672 | Roth et al. | May 1993 | A |
5211165 | Dumoulin et al. | May 1993 | A |
5275151 | Shockey et al. | Jan 1994 | A |
5423321 | Fontenot | Jun 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5517997 | Fontenot | May 1996 | A |
5622170 | Schulz | Apr 1997 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5872879 | Hamm | Feb 1999 | A |
5873842 | Brennen et al. | Feb 1999 | A |
5879306 | Fontenot et al. | Mar 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
6069698 | Ozawa et al. | May 2000 | A |
6081741 | Hollis | Jun 2000 | A |
6178346 | Amundson et al. | Jan 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6319227 | Mansouri-Ruiz | Nov 2001 | B1 |
6343227 | Crowley | Jan 2002 | B1 |
6398721 | Nakamura et al. | Jun 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6593884 | Gilboa et al. | Jul 2003 | B1 |
6597941 | Fontenot et al. | Jul 2003 | B2 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6685666 | Fontenot | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6690966 | Rava et al. | Feb 2004 | B1 |
6701181 | Tang et al. | Mar 2004 | B2 |
6711426 | Benaron et al. | Mar 2004 | B2 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6892090 | Verard et al. | May 2005 | B2 |
6895267 | Panescu et al. | May 2005 | B2 |
7132645 | Korn | Nov 2006 | B2 |
7273056 | Wilson et al. | Sep 2007 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7366562 | Dukesherer et al. | Apr 2008 | B2 |
7366563 | Kleen et al. | Apr 2008 | B2 |
7396354 | Rychnovsky et al. | Jul 2008 | B2 |
7406346 | Kleen et al. | Jul 2008 | B2 |
7515265 | Alfano et al. | Apr 2009 | B2 |
7532920 | Ainsworth et al. | May 2009 | B1 |
7587236 | Demos et al. | Sep 2009 | B2 |
7603166 | Casscells, III et al. | Oct 2009 | B2 |
7729735 | Burchman | Jun 2010 | B1 |
7757695 | Wilson et al. | Jul 2010 | B2 |
7758499 | Adler | Jul 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7992573 | Wilson et al. | Aug 2011 | B2 |
8032200 | Tearney et al. | Oct 2011 | B2 |
8054469 | Nakabayashi et al. | Nov 2011 | B2 |
8060187 | Marshik-Geurts et al. | Nov 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8078261 | Imam | Dec 2011 | B2 |
8187189 | Jung et al. | May 2012 | B2 |
8267932 | Baxter et al. | Sep 2012 | B2 |
8369932 | Cinbis et al. | Feb 2013 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8571640 | Holman | Oct 2013 | B2 |
8597315 | Snow et al. | Dec 2013 | B2 |
8700358 | Parker, Jr. | Apr 2014 | B1 |
8781555 | Burnside et al. | Jul 2014 | B2 |
8798721 | Dib | Aug 2014 | B2 |
8968331 | Sochor | Mar 2015 | B1 |
8979871 | Tyc et al. | Mar 2015 | B2 |
9360630 | Jenner et al. | Jun 2016 | B2 |
9560954 | Jacobs et al. | Feb 2017 | B2 |
9622706 | Dick et al. | Apr 2017 | B2 |
9678275 | Griffin | Jun 2017 | B1 |
10231753 | Burnside et al. | Mar 2019 | B2 |
10327830 | Grant et al. | Jun 2019 | B2 |
10349890 | Misener et al. | Jul 2019 | B2 |
10492876 | Anastassiou et al. | Dec 2019 | B2 |
10568586 | Begin et al. | Feb 2020 | B2 |
10631718 | Petroff et al. | Apr 2020 | B2 |
10992078 | Thompson et al. | Apr 2021 | B2 |
11123047 | Jaffer et al. | Sep 2021 | B2 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20040242995 | Maschke | Dec 2004 | A1 |
20050033264 | Redinger | Feb 2005 | A1 |
20050261598 | Banet | Nov 2005 | A1 |
20060013523 | Childlers et al. | Jan 2006 | A1 |
20060036164 | Wilson et al. | Feb 2006 | A1 |
20060189959 | Schneiter | Aug 2006 | A1 |
20060200049 | Leo et al. | Sep 2006 | A1 |
20060241395 | Kruger et al. | Oct 2006 | A1 |
20060241492 | Boese et al. | Oct 2006 | A1 |
20070156019 | Larkin et al. | Jul 2007 | A1 |
20070201793 | Askins et al. | Aug 2007 | A1 |
20070287886 | Saadat | Dec 2007 | A1 |
20070299425 | Waner et al. | Dec 2007 | A1 |
20080039715 | Wilson | Feb 2008 | A1 |
20080082004 | Banet | Apr 2008 | A1 |
20080172119 | Yamasaki et al. | Jul 2008 | A1 |
20080183128 | Morriss et al. | Jul 2008 | A1 |
20080285909 | Younge et al. | Nov 2008 | A1 |
20090062634 | Say et al. | Mar 2009 | A1 |
20090137952 | Ramamurthy et al. | May 2009 | A1 |
20090234328 | Cox et al. | Sep 2009 | A1 |
20090304582 | Rousso et al. | Dec 2009 | A1 |
20090314925 | Van Vorhis et al. | Dec 2009 | A1 |
20100016729 | Futrell | Jan 2010 | A1 |
20100030063 | Lee et al. | Feb 2010 | A1 |
20100114115 | Schlesinger et al. | May 2010 | A1 |
20100312095 | Jenkins et al. | Dec 2010 | A1 |
20110144481 | Feer et al. | Jun 2011 | A1 |
20110166442 | Sarvazyan | Jul 2011 | A1 |
20110172680 | Younge et al. | Jul 2011 | A1 |
20110245662 | Eggers et al. | Oct 2011 | A1 |
20110295108 | Cox et al. | Dec 2011 | A1 |
20110313280 | Govari | Dec 2011 | A1 |
20120046562 | Powers et al. | Feb 2012 | A1 |
20120143029 | Silverstein | Jun 2012 | A1 |
20120184827 | Shwartz et al. | Jul 2012 | A1 |
20120184955 | Pivotto et al. | Jul 2012 | A1 |
20120321243 | Younge et al. | Dec 2012 | A1 |
20130028554 | Wong et al. | Jan 2013 | A1 |
20130096482 | Bertrand et al. | Apr 2013 | A1 |
20130104884 | Vazales et al. | May 2013 | A1 |
20130188855 | Desjardins et al. | Jul 2013 | A1 |
20130204124 | Duindam et al. | Aug 2013 | A1 |
20130211246 | Parasher | Aug 2013 | A1 |
20130296693 | Wenzel et al. | Nov 2013 | A1 |
20130310668 | Young | Nov 2013 | A1 |
20130324840 | Zhongping et al. | Dec 2013 | A1 |
20140121468 | Eichenholz | May 2014 | A1 |
20140221829 | Maitland et al. | Aug 2014 | A1 |
20140275997 | Chopra et al. | Sep 2014 | A1 |
20150029511 | Hooft et al. | Jan 2015 | A1 |
20150031987 | Pameijer et al. | Jan 2015 | A1 |
20150080688 | Cinbis et al. | Mar 2015 | A1 |
20150099979 | Caves et al. | Apr 2015 | A1 |
20150119700 | Liang et al. | Apr 2015 | A1 |
20150209113 | Burkholz et al. | Jul 2015 | A1 |
20150209117 | Flexman et al. | Jul 2015 | A1 |
20150254526 | Denissen | Sep 2015 | A1 |
20150320977 | Vitullo | Nov 2015 | A1 |
20160018602 | Govari et al. | Jan 2016 | A1 |
20160166326 | Bakker et al. | Jun 2016 | A1 |
20160166341 | Iordachita et al. | Jun 2016 | A1 |
20160184020 | Kowalewski et al. | Jun 2016 | A1 |
20160213432 | Flexman et al. | Jul 2016 | A1 |
20160354038 | Demirtas et al. | Dec 2016 | A1 |
20170020394 | Harrington | Jan 2017 | A1 |
20170079681 | Burnside et al. | Mar 2017 | A1 |
20170082806 | Van Der Mark et al. | Mar 2017 | A1 |
20170196479 | Liu et al. | Jul 2017 | A1 |
20170201036 | Cohen et al. | Jul 2017 | A1 |
20170215973 | Flexman et al. | Aug 2017 | A1 |
20170231699 | Flexman et al. | Aug 2017 | A1 |
20170273542 | Au | Sep 2017 | A1 |
20170273565 | Ma et al. | Sep 2017 | A1 |
20170273628 | Ofek et al. | Sep 2017 | A1 |
20170311901 | Zhao et al. | Nov 2017 | A1 |
20170319279 | Fish et al. | Nov 2017 | A1 |
20180095231 | Lowell et al. | Apr 2018 | A1 |
20180113038 | Janabi-Sharifi et al. | Apr 2018 | A1 |
20180140170 | Van Putten et al. | May 2018 | A1 |
20180235709 | Donhowe et al. | Aug 2018 | A1 |
20180239124 | Naruse et al. | Aug 2018 | A1 |
20180250088 | Brennan et al. | Sep 2018 | A1 |
20180264227 | Flexman et al. | Sep 2018 | A1 |
20180279909 | Noonan et al. | Oct 2018 | A1 |
20180289390 | Amorizzo et al. | Oct 2018 | A1 |
20180289927 | Messerly | Oct 2018 | A1 |
20180339134 | Leo | Nov 2018 | A1 |
20180360545 | Cole et al. | Dec 2018 | A1 |
20190059743 | Ramachandran et al. | Feb 2019 | A1 |
20190110844 | Misener et al. | Apr 2019 | A1 |
20190231272 | Yamaji | Aug 2019 | A1 |
20190237902 | Thompson et al. | Aug 2019 | A1 |
20190321110 | Grunwald et al. | Oct 2019 | A1 |
20190343424 | Blumenkranz et al. | Nov 2019 | A1 |
20190357875 | Qi et al. | Nov 2019 | A1 |
20190374130 | Bydlon et al. | Dec 2019 | A1 |
20200046434 | Graetzel et al. | Feb 2020 | A1 |
20200054399 | Duindam et al. | Feb 2020 | A1 |
20200305983 | Yampolsky et al. | Oct 2020 | A1 |
20210045814 | Thompson et al. | Feb 2021 | A1 |
20210068911 | Walker et al. | Mar 2021 | A1 |
20210298680 | Sowards et al. | Mar 2021 | A1 |
20210244311 | Zhao et al. | Aug 2021 | A1 |
20210268229 | Sowards et al. | Sep 2021 | A1 |
20210271035 | Sowards et al. | Sep 2021 | A1 |
20210275257 | Prior et al. | Sep 2021 | A1 |
20210401456 | Cox et al. | Dec 2021 | A1 |
20210401509 | Misener et al. | Dec 2021 | A1 |
20210402144 | Messerly | Dec 2021 | A1 |
20220011192 | Misener et al. | Jan 2022 | A1 |
20220034733 | Misener et al. | Feb 2022 | A1 |
20220110695 | Sowards et al. | Apr 2022 | A1 |
20220152349 | Sowards et al. | May 2022 | A1 |
20220160209 | Sowards et al. | May 2022 | A1 |
20220211442 | McLaughlin et al. | Jul 2022 | A1 |
20220233246 | Misener et al. | Jul 2022 | A1 |
20220369934 | Sowards et al. | Nov 2022 | A1 |
20230081198 | Sowards et al. | Mar 2023 | A1 |
20230097431 | Sowards et al. | Mar 2023 | A1 |
20230101030 | Misener et al. | Mar 2023 | A1 |
20230108604 | Messerly et al. | Apr 2023 | A1 |
20230126813 | Sowards et al. | Apr 2023 | A1 |
20230243715 | Misener et al. | Aug 2023 | A1 |
20230248444 | Misener et al. | Aug 2023 | A1 |
20230251150 | Misener et al. | Aug 2023 | A1 |
Number | Date | Country |
---|---|---|
102016109601 | Nov 2017 | DE |
2240111 | Oct 2010 | EP |
3545849 | Oct 2019 | EP |
3705020 | Sep 2020 | EP |
20190098512 | Aug 2019 | KR |
9964099 | Dec 1999 | WO |
1999064099 | Dec 1999 | WO |
2006122001 | Nov 2006 | WO |
2009155325 | Dec 2009 | WO |
2011121516 | Oct 2011 | WO |
2011141830 | Nov 2011 | WO |
2011150376 | Dec 2011 | WO |
2012064769 | May 2012 | WO |
2015074045 | May 2015 | WO |
2016038492 | Mar 2016 | WO |
2016061431 | Apr 2016 | WO |
2016051302 | Apr 2016 | WO |
2018096491 | May 2018 | WO |
2019037071 | Feb 2019 | WO |
2019046769 | Mar 2019 | WO |
2019070423 | Apr 2019 | WO |
2019230713 | Dec 2019 | WO |
2020182997 | Sep 2020 | WO |
2021030092 | Feb 2021 | WO |
2021108688 | Jun 2021 | WO |
2021108697 | Jun 2021 | WO |
2021138096 | Jul 2021 | WO |
2022031613 | Feb 2022 | WO |
2022081723 | Apr 2022 | WO |
2022150411 | Jul 2022 | WO |
2022164902 | Aug 2022 | WO |
2022245987 | Nov 2022 | WO |
2023043954 | Mar 2023 | WO |
2023049443 | Mar 2023 | WO |
2023055810 | Apr 2023 | WO |
2023076143 | May 2023 | WO |
Entry |
---|
PCT/US2020/062396 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 2, 2021. |
PCT/US2020/062407 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 11, 2021. |
PCT/US2020/062396 filed Nov. 25, 2020 International Preliminary Report on Patentability dated Jan. 29, 2021. |
PCT/US2020/062407 filed Nov. 25, 2020 International Preliminary Report on Patentability dated Jan. 25, 2021. |
PCT/US2022/011347 filed Jan. 5, 2022 International Search Report and Written Opinion dated May 3, 2022. |
PCT/US2022/013897 filed Jan. 26, 2022 International Search Report and Written Opinion dated May 11, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Non-Final Office Action dated Jul. 12, 2022. |
PCT/US2021/054802 filed Oct. 13, 2021 International Search Report and Written Opinion dated Feb. 2, 2022. |
PCT/US2021/060849 filed Nov. 24, 2021 International Search Report and Written Opinion dated Mar. 9, 2022. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Apr. 22, 2022. |
U.S. Appl. No. 17/185,777, filed Feb. 25, 2021 Non-Final Office Action dated Feb. 9, 2022. |
PCT/US2018/026493 filed Apr. 6, 2018 International Search Report and Written Opinion dated Jun. 22, 2018. |
PCT/US2020/044801 filed Aug. 3, 2020 International Search Report and Written Opinion dated Oct. 26, 2020. |
PCT/US2021/019713 filed Feb. 25, 2021 International Search Report and Written Opinion dated Jul. 6, 2021. |
PCT/US2021/020079 filed Feb. 26, 2021 International Search Report and Written Opinion dated Jun. 4, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Jun. 30, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Final Office Action dated Nov. 10, 2020. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated Mar. 12, 2021. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated May 29, 2020. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Non-Final Office Action dated Oct. 13, 2021. |
PCT/US2022/029894 filed May 18, 2022, International Search Report and Written Opinion dated Sep. 1, 2022. |
U.S. Appl. No. 17/105,259, filed Nov. 25, 2020, Notice of Allowance dated Jul. 20, 2022. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Non-Final Office Action dated Aug. 11, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Non-Final Office Action dated Sep. 12, 2022. |
PCT/US2021/020732 filed Mar. 3, 2021 International Search Report and Written Opinion dated Jul. 5, 2021. |
PCT/US2021/038899 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 6, 2021. |
PCT/US2021/038954 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 28, 2021. |
PCT/US2021/041128 filed Jul. 9, 2021 International Search Report and Written Opinion dated Oct. 25, 2021. |
PCT/US2021/044216 filed Aug. 2, 2021 International Search Report and Written Opinion dated Nov. 18, 2021. |
Jackle Sonja et al. “Three dimensional guidance including shape sensing of a stentgraft system for endovascular aneurysm repair.” International Journal of Computer Assisted Radiology and Surgery, Springer DE. vol. 15, No. 6, May 7, 2020. |
PCT/US2022/043706 filed Sep. 16, 2022 International Search Report and Written Opinion dated Nov. 24, 2022. |
PCT/US2022/044696 filed Sep. 26, 2022 International Search Report and Written Opinion dated Jan. 23, 2023. |
PCT/US2022/045051 filed Sep. 28, 2022 International Search Report and Written Opinion dated Jan. 2, 2023. |
PCT/US2022/047538 filed Oct. 24, 2022 International Search Report and Written Opinion dated Jan. 26, 2023. |
U.S. Appl. No. 15/947,267, filed Apr. 6, 2018 Examiner's Answer dated Novemeber 28, 2022. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Notice of Allowance dated Dec. 9, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Notice of Allowance dated Nov. 3, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Notice of Allowance dated Jan. 19, 2023. |
Fiber Optic RealShape (FORS) technology—research. Philips. (Oct. 18, 2018). Retrieved Feb. 28, 2023, from https:// www.philips.com/a-w/research/research-programs/fors.html (Year: 2018). |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Restriction Requirement dated Mar. 13, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Restriction Requirement dated Mar. 7, 2023. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Corrected Notice of Allowability dated Feb. 23, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Non-Final Office Action dated Mar. 15, 2023. |
EP 20853352.1 filed Mar. 7, 2022 Extended European Search Report dated Jul. 27, 2023. |
PCT/US2023/019239 filed Apr. 20, 2023 International Search Report and Written Opinion dated Jul. 20, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Non-Final Office Action dated Jun. 22, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Non Final Office Action dated May 30, 2023. |
Number | Date | Country | |
---|---|---|---|
20210154440 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
62940107 | Nov 2019 | US |